These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 33730984)

  • 21. COVID-19 pandemic, coronaviruses, and diabetes mellitus.
    Muniyappa R; Gubbi S
    Am J Physiol Endocrinol Metab; 2020 May; 318(5):E736-E741. PubMed ID: 32228322
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Editor's Note: COVID-19 and Bioethics].
    Pastor LM
    Cuad Bioet; 2020; 31(102):131-138. PubMed ID: 32910667
    [No Abstract]   [Full Text] [Related]  

  • 23. Response to: Is newly diagnosed diabetes a stronger risk factor than pre-existing diabetes for COVID-19 severity?
    Lippi G; Sanchis-Gomar F; Henry BM
    J Diabetes; 2021 Feb; 13(2):179-180. PubMed ID: 33128349
    [No Abstract]   [Full Text] [Related]  

  • 24. Is newly diagnosed diabetes a stronger risk factor than pre-existing diabetes for COVID-19 severity?
    Sathish T; de Mello GT; Cao Y
    J Diabetes; 2021 Feb; 13(2):177-178. PubMed ID: 33107708
    [No Abstract]   [Full Text] [Related]  

  • 25. Inflammation and hypercoagulopathy are predominant risk factors of severity in COVID-19 patients with diabetes mellitus: Summary of a meta-analysis.
    Dhar SK; Sachdeva K; Das M
    Diabetes Metab Syndr; 2021; 15(2):639-641. PubMed ID: 33676871
    [No Abstract]   [Full Text] [Related]  

  • 26. Asian journal of psychiatry and COVID-19; A window with a transcultural view - Reply to editor's letter.
    Badrfam R; Zandifar A
    Asian J Psychiatr; 2021 Apr; 58():102604. PubMed ID: 33611085
    [No Abstract]   [Full Text] [Related]  

  • 27. Editor's Note: March 2021.
    Kennedy Inst Ethics J; 2021; 31(1):vii-viii. PubMed ID: 33716224
    [No Abstract]   [Full Text] [Related]  

  • 28. [The agreed experts' position of the Eurasian Association of Therapists on tactics of management of patients with comorbid pathology infected with SARS-Cov-2].
    Arutiunov GP; Tarlovskaia EI; Koziolova NA; Boldina MV; Batiushin MM; Ametov AS; Arutiunov AG; Belevskii AS; Galstian GR; Grigor'eva NI; Dzhunusbekova GA; Esaian AM; Mal'chikova SV; Mit'kovskaia NP; Mkrtumian AM; Orlova IA; Petrova MM; Rebrov AP; Ruzanov DI; Salukhov VV; Sisakian AS; Skibitskii VV; Sugraliev AB; Fomin IV; Khalimov IS; Chesnikova AI; Shaposhnik II; Shestakova MV
    Ter Arkh; 2020 Oct; 92(9):108-124. PubMed ID: 33346439
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autonomic dyshomeostasis in patients with diabetes mellitus during COVID-19.
    Boccardi V
    Nat Rev Endocrinol; 2021 Mar; 17(3):189. PubMed ID: 33452491
    [No Abstract]   [Full Text] [Related]  

  • 30. SARS-CoV-2 perturbs the renin-angiotensin system and energy metabolism.
    Mori J; Oudit GY; Lopaschuk GD
    Am J Physiol Endocrinol Metab; 2020 Jul; 319(1):E43-E47. PubMed ID: 32469255
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recommendations for the care of patients with diabetes mellitus with risk factors or established cardiovascular disease and SARS-CoV-2mellitus con factores de riesgo o enfermedad cardiovascular establecida y SARS-CoV-2.
    Alcocer-Gamba MA; Gutiérrez-Fajardo P; Sosa-Caballero A; Cabrera-Rayo A; Faradji-Hazan RN; Padilla-Padilla FG; Garnica-Cuellar JC; Hernández-Arispe LM; Reyes-Cianeros FA; León-Suárez A; de-Jesús-Rivera J; Mancillas-Adame L; Gaxiola-Macias M; Márquez-Rodríguez E; Miranda-Malpica E; Sanchez-Pedraza V; Lara-Martínez DS; Segovia-Palomo A; Nava-Hernández A; Rivera-Reyes R
    Arch Cardiol Mex; 2020; 90(Supl):77-83. PubMed ID: 32523151
    [TBL] [Abstract][Full Text] [Related]  

  • 32. COVID 19 could trigger global diabetes burden - A hypothesis.
    Mukherjee S; Banerjee O; Singh S; Maji BK
    Diabetes Metab Syndr; 2020; 14(5):963-964. PubMed ID: 32604015
    [No Abstract]   [Full Text] [Related]  

  • 33. Diabetes Mellitus and COVID-19: Unholy Association of Two Pandemics.
    Kamrul-Hasan AB; Nessa A; Debnath CR
    Mymensingh Med J; 2021 Jan; 30(1):1-2. PubMed ID: 33397842
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Observational research on severe COVID-19 in diabetes.
    Stehouwer CDA
    Lancet Diabetes Endocrinol; 2021 Feb; 9(2):56-57. PubMed ID: 33357490
    [No Abstract]   [Full Text] [Related]  

  • 35. Microvascular disease in diabetes and severe COVID-19 outcomes.
    Corcillo A; Whyte MB; Vas P; Karalliedde J
    Lancet Diabetes Endocrinol; 2021 Apr; 9(4):200-201. PubMed ID: 33740436
    [No Abstract]   [Full Text] [Related]  

  • 36. Predicting Mortality Due to SARS-CoV-2: A Mechanistic Score Relating Obesity and Diabetes to COVID-19 Outcomes in Mexico.
    Bello-Chavolla OY; Bahena-López JP; Antonio-Villa NE; Vargas-Vázquez A; González-Díaz A; Márquez-Salinas A; Fermín-Martínez CA; Naveja JJ; Aguilar-Salinas CA
    J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32474598
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glucovigilance in COVID-19.
    Lamptey R; Ahomagnon S; Acheampong F; Kalra S
    J Pak Med Assoc; 2020 May; 70(Suppl 3)(5):S80-S82. PubMed ID: 32515386
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microvascular disease in diabetes and severe COVID-19 outcomes - Authors' reply.
    Colhoun HM; McGurnaghan SJ; McKeigue PM
    Lancet Diabetes Endocrinol; 2021 Apr; 9(4):201. PubMed ID: 33740437
    [No Abstract]   [Full Text] [Related]  

  • 39. Preexisting prediabetes and the severity of COVID-19.
    Sathish T; Cao Y; Kapoor N
    Prim Care Diabetes; 2021 Feb; 15(1):28-29. PubMed ID: 32958435
    [No Abstract]   [Full Text] [Related]  

  • 40. Letter to the Editor regarding 'COVID-19 and diabetes: What does the clinician need to know?'.
    Abbasi-Oshaghi E; Mirzaei F; Khodadadi I
    Prim Care Diabetes; 2021 Feb; 15(1):30. PubMed ID: 33162350
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.